Cashu
Curis Advances AML Treatment with Promising Emavusertib Clinical Data at ASH Annual Meeting
21 days ago
Stocks
Health Care
cris
Curis
NASDAQ: CRIS
-0.02 (-2.27%)
0.9871
USD
At close at Jan 01, 18:35 UTC
Latest Curis News
prnewswire.com
Curis Provides Updated Data from its Frontline AML Triplet Study
23 days ago
prnewswire.com
Curis to Present at Upcoming 30th Annual SNO Meeting
about 2 months ago
prnewswire.com
CRIS LACY NAMED CHAIR & PRESIDENT OF NEWLY REBRANDED WARNER RECORDS NASHVILLE
about 2 months ago
benzinga.com
Earnings Scheduled For November 6, 2025
about 2 months ago
prnewswire.com
Curis Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
3 months ago
prnewswire.com
Curis to Present at Upcoming Healthcare Conferences in September
4 months ago
benzinga.com
A Peek at Curis's Future Earnings
5 months ago
prnewswire.com
Michael Baker International Names Aaron Gies, C.S.P., CRIS, Vice President, Health and Safety
10 months ago
finance.yahoo.com
Curis Announces the 3rd Annual Symposium on IRAK4 in Cancer
over 1 year ago
finance.yahoo.com
Curis to Participate at the Upcoming 2024 Cantor Fitzgerald Global Healthcare Conference
over 1 year ago
Join our newsletter to keep up to date with us!
Cashu is the #1 way to stay ahead of the markets, know why your favourite stocks are moving and access valuation signals that smash the market.